Table 2.

Evolution characteristics of patients according to eligibility for phage therapy after management of PJI

	Group 1 Ineligible	Group 2 Eligible	p-value
Time from diagnosis to surgery (mean in days)	13.6 ± 42.8	8.7 ± 12.1	0.52
Antibiotherapy duration (mean in days)	56.7 ± 20.3	61.1 ± 24.0	0.39
Intravenous therapy (mean in days)	9.6 ± 7.4	17.2 ± 7.5	0.02
Serious adverse events (n, %)	3 (8.3)	11 (26.2)	0.08
Hospitalization length (mean in days)	18.3 ± 15.3	42.5 ± 32.0	< 0.001
Relapse (n, %)	5 (13.9)	9 (21.4)	0.23

Plus-minus values are means +/- SD